Neutral endopeptidase 24.11 in neutrophils modulates protective effects of natriuretic peptides against neutrophils-induced endothelial cytotoxity

Journal of Clinical Investigation

Volumn 97, Issue 10, 1996, Pages 2192-2203

  Matsumura, Toshiyuki ^a   Kugiyama, Kiyotaka ^a   Sugiyama, Seigo ^a   Ohgushi, Masamichi ^a   Yamanaka, Kyozo ^b   Suzuki, Makoto ^b   Yasue, Hirofumi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b PFIZER INC   (United States)

Author keywords

acute myocardial infarction; atrial natriuretic peptide; brain natriuretic peptide; CD10; endothelial cells

Indexed keywords

8 BROMO CYCLIC GMP; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CALCIUM; CANDOXATRILAT; CD18 ANTIGEN; CYCLIC GMP; CYCLOHEXIMIDE; DACTINOMYCIN; LEUKOCYTE ELASTASE; MEMBRANE METALLOENDOPEPTIDASE; METALLOPROTEINASE INHIBITOR; MYELOPEROXIDASE; PHOSPHORAMIDON; UNCLASSIFIED DRUG; ZYMOSAN;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME RELEASE; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE ADHERENCE INHIBITION; MALE; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY BURST;

EID: 0029931492     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118660     Document Type: Article

References (69)

1. de Bold, A.J. 1985. Atrial natriuretic factor: a hormone produced by the heart. Science (Wash. DC). 230:767-770.
2. Laragh, J.H. 1985. Atrial natriuretic hormone: the renin aldosterone axis and blood pressure-electrolyte homeostasis. N. Engl. J. Med. 313:1330-1340.
3. Needleman, P., and J.E. Greenwald. 1986. Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte, and blood pressure homeostasis. N. Engl. J. Med. 314:828-834.
4. Ballermann, B.J., and B.M. Brenner. 1986. Role of atrial peptides in body fluid homeostasis. Circ. Res. 58:619-630.
5. Genest, J., and M. Cantin. 1987. Atrial natriuretic factor. Circulation. 75(suppl I): I-118-I-124.
6. Floras, J.S. 1990. Sympathoinhibitory effects of atrial natriuretic factor in normal humans. Circulation. 81:1860-1873.
7. Yasue, H., M. Yoshimura, H. Sumida, K. Koichi, K. Kugiyama, M. Jougasaki, H. Ogawa, K. Okumura, M. Mukoyama, and K. Nakao. 1994. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 90:195-203.
8. Morita, E., H. Yasue, M. Yoshimura, H. Ogawa, M. Jougasaki, T. Matsumura, M. Mukoyama, and K. Nakao. 1993. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation. 88: 82-91.
9. Omland, T., T. Aarsland, A. Aakvaag, R. T. Lie, and K. Dickstein. 1993. Prognostic value of plasma atrial natriuretic factor, norepinephrine and epinephrine in acute myocardial infarction. Am. J. Cardiol. 72:255-259.
10. Yasue, H., K. Obata, K. Okumura, M. Kurose, H. Ogawa, K. Matsuyama, M. Jougasaki, Y. Saito, K. Nakao, and H. Imura. 1989. Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy. J. Clin. Invest. 83:46-51.
11. Erdös, E.G., and R.A. Skidgel. 1989. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB. J. 3:145-151.
12. Johnson, A.R., J. Ashton, W.W. Schultz, and E.G. Erdös. 1985. Neutral metalloendopeptidase in human lung tissue and cultured cells. Am. Rev. Respir. Dis. 132:564-568.
13. Malfroy, B., J.P. Swerts, A. Guyon, B.P. Roques, and J.C. Schwartz. 1978. High-affinity enkephalin-degrading peptidase in brain is increased after morphine. Nature (Lond.). 276:523-526.
14. Connelly, J.C., R.A. Skidgel, W.W. Schulz, A.R. Johnson, and E.G. Erdös. 1985. Neutral endopeptidase 24.11 in human neutrophils: cleavage of chemotactic peptide. Proc. Natl. Acad. Sci. USA. 82:8737-8741.
15. Shipp, M.A., G. B. Stefano, L. D'Adamio, S.N. Switzer, F.D. Howard, J. Sinisterra, B. Scharrer, and E.L. Reinherz. 1990. Downregulation of enkephalin-mediated inflammatory responses by CD10/neutral endopeptidase 24.11. Nature (Lond.). 347:394-396.
16. Shipp, M.A., G.B. Stefano, S.N. Switzer, J.D. Griffin, and E.L. Reinherz. 1991. CD10 (CALLA)/Neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesion proteins and is itself regulated by neutrophil activation. Blood. 78:1834-1841.
17. Iwamoto, I., A. Kimura, K. Ochiai, H. Tomioka, and S. Yoshida. 1991. Distribution of neutral endopeptidase activity in human blood leukocytes. J. Leukocyte Biol. 49:116-125.
18. Letarte, M., S. Vera, R. Tran, J.B.L. Addis, R.J. Onizuka , E.J. Quackenbush, C.V. Jongeneel, and R.R. McInnes. 1988. Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase. J. Exp. Med. 168:1247-1253.
19. Shipp, M.A., N.E. Richardson, P.H. Sayre, N.R. Brown, E.L. Masteller, L.K. Clayton, J. Ritz, and E.L. Reinherz. 1988. Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein. Proc. Natl. Acad. Sci. USA. 85:4819-4823.
20. Willerson, J.T., J.T. Watson, I. Hutton, G.H. Templeton, and D.E. Fixler. 1975. Reduced myocardial reflow and increased coronary vascular resistance following prolonged myocardial ischemia in the dog. Circ. Res. 36:771-781.
21. Ku, D.D. 1982. Coronary vascular reactivity after acute myocardial ischemia. Science (Wash. DC). 218:576-578.
22. VanBenthuysen, K.M., I.F. McMurtry, and L.D. Horwitz. 1987. Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J. Clin. Invest. 79:265-274.
23. Tsao, P.S., N. Aoki, D.J. Lefer, G. Johnson, and A.M. Lefer. 1990. Time course of endothelial dysfunction and myocardial ishemia and reperfusion in the cat. Circulation. 82:1402-1412.
24. Lefer, A.M., P.S. Tsao, D.J. Lefer, and X. Ma. 1991. Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J. 5:2029-2034.
25. Mehta, J., J. Dinerman, P. Mehta, T.G.P. Saldeen, D. Lawson, W.H. Donnelly, and R. Wallin. 1989. Neutrophil function in ischemic heart disease. Circulation. 79:549-556.
26. Servi, S.D., A. Mazzone, G. Ricevuti, A. Fioravanti, E. Bramucci, L. Angoli, G. Stefano, and G. Specchia. 1990. Granulocyte activation after coronary angioplasty in humans. Circulation. 82:140-146.
27. Inauen, W., D.N. Granger, C.J. Meininger, M.E. Schelling, H.J. Granger, and P.R. Kvietys. 1990. Anoxia-reoxygen-induced, neutrophil-mediated endothelial cell injury: role of elastase. Am. J. Physiol. 259:H925-H931.
28. Harlan, J.M., P.D. Killen, L.A. Harker, and G.E. Striker. 1981. Neutrophil-mediated endothelial injury in vitro. Mechanisms of cell detachment. J. Clin. Invest. 68:1394-1403.
29. Roques, B.P., F. Noble, V. Dauge, M.C. Fournie-Zalunski, and A. Beaumont. 1993. Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol. Rev. 45:87-146.
30. Hudgin, R.L., S.E. Charleson, M. Zimmerman, R. Mumford, and P.L. Wood. 1981. Enkephalinase: selective peptide inhibitors. Life Sci. 29:2593-2601.
31. Danilewicz, J.C., P.L. Barclay, I.T. Barnish, D. Brown, S.F. Campbell, K. James, G.M.R. Samuels, N.K. Terrett, and M.J. Wythes. 1989. UK-69,578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic. Biochem. Biophys. Res. Commun. 164:58-65.
32. Sugiyama, S., K. Kugiyama, M. Ohgushi, K. Fujimoto, and H. Yasue. 1994. Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries. Role of protein kinase C. Circ. Res. 74:565-575.
33. Kawabata, K., M. Suzuki, M. Sugitani, K. Imaki, M. Toda, and T. Miyamoto. 1991. ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem. Biophys. Res. Commun. 177:814-820.
34. Kugiyama, K., T. Sakamoto, I. Misumi, S. Sugiyama, M. Ohgushi, H. Ogawa, M. Horiguchi, and H. Yasue. 1994. Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells. Circ. Res. 73: 335-343.
35. Sugama, Y., C. Tiruppathi, K. Janakidevi, T.T. Andersen, J.W. Fenton II, and A.B. Malik. 1992. Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion. J. Cell Biol. 119:935-944.
36. Zimmerman, B.J., D.C. Anderson, and D.N. Granger. 1992. Neuropeptides promote neutrophil adherence to endothelial cell monolayers. Am. J. Physiol. 263:G678-G682.
37. Hughes, H., B. Mathews, M.L. Lenz, and J.R. Guyton. 1994. Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol. Arterioscler. Thromb. 14:1177-1185.
38. Moldow, C.F., and H.S. Jacob. 1984. Endothelial culture, neutrophil or enzymic generation of free radicals: in vitro methods for the study of endothelial injury. Methods Enzymol. 105:378-385.
39. Vijayaraghavan, J., A.G. Scicli, O.A. Carretero, C. Slaughter, C. Moomaw, and L.B. Hersh. 1990. The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase). J. Biol. Chem. 265:14150-14155.
40. Gros, C., A. Souque, J.C. Schwartz, J. Duchier, A. Cournot, P. Baumer, and J.M. Lecomte. 1989. Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan. Proc. Natl. Acad. Sci. USA. 86:7580-7584.
41. 2+ and tumor necrosis factor-induced degranulation in adherent human neutrophils. J. Biol. Chem. 265: 14358-14363.
42. Laudanna, C., G. Constanitn, P. Baron, E. Scarpini, G. Scarlato, G. Cabrini, C. Dechecchi, F. Rossi, M.A. Cassatella, and G. Berton. 1993. Sulfatides trigger increase of cytosolic free calcium and enhanced expression of tumor necrosis fator-α and interleukin-8 mRNA in human neutrophils J. Biol. Chem. 269:4021-4026.
43. Jaconi, M.E.E., R.W. Rivest, W. Schlegel, C.B. Wollheim, D. Pittet, and P.D. Lew. 1988. Spontaneous and chemoattractant-induced oscillations of cytoslic free calcium in single adherent human neutrophils. J. Biol. Chem. 263: 10557-10560.
44. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440-3450.
45. x-containing oligosaccharide attenuates myocardial reperfusion injury in cats. J. Clin. Invest. 93:1140-1148.
46. Ma, X-L., D.J. Lefer, A.M. Lefer. Baron, and R. Rothlein. 1992. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation. 86:937-946.
47. Bradley, P.P., D.A. Priebat, R.D. Christensen, and G. Rothstein. 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78:206-209.
48. Lum, H., L. Gibbs, L. Lai, and A.B. Malik. 1994. CD18 integrin-dependent endothelial injury: effects of opsonized zymosan and phorbol ester activation. J. Leukocyte Biol. 55:58-63.
49. Woodman, R.C., P.H. Reinhardt, S. Kanwar, F.L. Johnston, and P. Kubes. 1993. Effects of human neutrophil elastase (HNE) on neutrophil function in vitro and in inflamed microvessels. Blood. 82:2188-2195.
50. Morishita, Y., T. Sano, K. Ando, Y. Saitoh, H. Kase, K. Yamada, and Y. Matsuda. 1991. Microbial polysaccharide, HS-142-1, competitively and selectively inhibits and binding to its guanylyl cyclase-containing receptor. Biochem. Biophys. Res. Commun. 176:949-957.
51. Park, K.H., and R. Levi. 1994. Hypoxic coronary vasodilatation and cGMP overproduction and blocked by a nitric oxide synthase inhibitor, but not by a guanylyl cyclase ANF receptor antagonist. Eur. J. Pharmacol. 256:99-102.
52. Appel, R.G., G.R. Dubyak, and M.J. Dunn. 1987. Effect of atrial natriuretic factor on cytosolic free calcium in rat glomerular mesangial cells. FEBS Lett. 224:396-400.
53. Rogers, J., R.G. Hughes, and E.K. Matthews. 1988. Cyclic GMP inhibits protein kinase C-mediated secretion in rat pancreatic acini. J. Biol. Chem. 263: 3713-3719.
54. Schröder, H., P. Ney, I. Woditsch, and K. Schrör. 1990. Cyclic GMP mediates SIN-1-induced inhibition of human polymorphonuclear leukocytes. Eur. J. Pharmacol. 182:211-218.
55. Moilanen, E., P. Vuorinen, H. Kankaanranta, T. Metsä-Ketelä, and H. Vapaatalo. 1993. Inhibition by nitric oxide-donors of human polymorphonuclear leukocyte functions. Br. J. Pharmacol. 109:852-858.
56. Niu, X., C.W. Smith, and P. Kubes. 1994. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ. Res. 74:1133-1140.
57. Dewald, B.M., M. Thelen, and M. Baggiolini. 1988. Two transduction sequences are necessary for neutrophil activation by receptor agonist. J. Biol. Chem. 263:16179-16184.
58. Saito, Y., K. Nakao, K. Nishimura, A. Sugawara, K. Okumura, K. Obata, R. Sonoda, T. Ban, H. Yasue, and H. Imura. 1987. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation. 76:115-124.
59. Yoshimura, M., H. Yasue, E. Morita, N. Sakaino, M. Jougasaki, M. Kurose, M. Mukoyama, Y. Saito, K. Nakao, and H. Imura. 1991. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation. 84:1581-1588.
60. Okumura, K., H. Yasue, H. Fujii, K. Kugiyama, K. Matsuyama, M. Yoshimura, M. Jougasaki, K. Kikuta, H. Kato, H. Tanaka, H. Sumida, and K. Nakao. 1995. Effects of brain (B-type) natriuretic peptide on coronary artery diameter and coronary hemodynamic variables in humans: comparison with effects on systemic hemodynamic variables. J. Am. Coll. Cardiol. 25:342-348.
61. Münzel, T., S. Kurz, J. Holtz, R. Busse, H. Steinhauer, J. Hanjörg, and D. Helmut. 1992. Neurohormonal inhibition and hemodynamic unloading during prolonged inhibition of ANF degradation in patients with severe chronic heart failure. Circulation. 86:1089-1098.
62. Seymour, A.A., M.M. Asaad, V.M. Lanoce, S.A. Fennell, H.S. Cheung, and W.L. Rogers. 1993. Inhibition of neutral endopeptidase 3.4.24.11 in conscious dogs with pacing induced heart failure. Cardiovasc. Res. 27:1015-1023.
63. Wiedermann, C.J., M. Niedermühlbichler, and H. Braunsteiner. 1992. Priming of polymorphonuclear neutrophils by atrial natriuretic peptide in vitro. J. Clin. Invest. 89:1580-1586.
64. López Farré, A., A. Riesco, G. Espinosa, E. Digiuni, M.R. Cernadas, V. Alvarez, M. mentón, F. Rivas, M.J. Gallego, J. Egido, S. Casado, and C. Caramelo. 1993. Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation. 88:1166-1171.
65. Skidgel, R.A., H.L. Jackman, and E.G. Erdös. 1991. Metabolism of substance P and bradykinin by human neutrophils. Biochem. Pharmacol. 41:1335-1344.
66. Engler, R.L., M.D. Dahlgren, M.A. Peterson, A. Dobbs, and W. Schmid-Schönbein. 1986. Accumulation of polymorphonuclear leukocytes during 3-h experimental myocardial ischemia. Am. J. Physiol. 251:H93-100.
67. Dreyer, W.J., L.H. Michael, T. Nguyen, C.W. Smith, D.C. Anderson, M.L. Entman, and R.D. Rossen. 1992. Kinetics of C5a release in cardiac lymph of dogs experiencing coronary artery ischemia-reperfusion injury. Circ. Res. 71: 1518-1524.
68. Yasuda, M., K. Takeuchi, M. Hiruma, H. Iida, A. Tahara, H. Itagane, I. Toda, K. Akioka, M. Teragaki, H. Oku, Y. Kanayama, T. Takeda, W.P. Kolb, and J.D. Tamerius. 1990. The complement system in ischemic heart disease. Circulation. 81:156-163.
69. Werfel, T., G. Sonntag, M.H. Weber, and O. Götze. 1991. Rapid increases in the membrane expression of neutral endopeptidase (CD10), aminopeptidase N (CD13), tyrosine phosphatase (CD45), and Fcγ-RIII (CD16) upon stimulation of human peripheral leukocytes with human C5a. J. Immunol. 147:3909-3914.